Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Oventus Announce Appendix 4C and Quarterly Business Review (ASX:OVN)

Oventus Quarterly Business Review Q1 FY2020: Investing in Growth Key highlights: Flagship device for the treatment of Obstructive Sleep Apnoea (OSA), the O2Vent® Optima granted FDA clea...read more

Oventus Announce Appendix 4G and Corporate Governance Statement (ASX:OVN)

Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations For further information please download the attached PDF:

Oventus Announce Annual Report to Shareholders (ASX:OVN)

Oventus Medical Limited Annual Report 2019 To view the report please download the attached PDF:

Oventus Announce Notice of Annual General Meeting & Proxy Form (ASX:OVN)

Notice of Annual General Meeting & Explanatory Statement To be held at: Thomson Geer, Level 28, Waterfront Place 1 Eagle Street, Brisbane, Queensland 4000 To be held on: Friday 22 November 201...read more

Oventus Announce First lab in lab sites operational in Canada and US (ASX:OVN)

First ‘lab in lab’ sites operational in Canada and the US following official launch of O2Vent® Optima oral device in the US Key points: The first ‘lab in lab’ ...read more

Oventus Announce Reinstatement to Official Quotation (ASX:OVN)

For further information please download the attached PDF:

Oventus Announce Response to ASX Price Query (ASX:OVN)

Oventus Medical Limited (“OVN”): Price Query Please find attached OVN’s response to your query dated 23 September 2019 regarding OVN’s share trading on 23 September 2019. ...read more

Oventus Announce Suspension from Official Quotation (ASX:OVN)

For further information please download the attached PDF:

Oventus Announce Pause in Trading (ASX:OVN)

For further information please download the attached PDF:

Oventus Announce Cleansing Statement (ASX:OVN)

Cleansing Statement NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT For further information please download the attached PDF:

Oventus Announce Appendix 3B (ASX:OVN)

Appendix 3B New issue announcement, application for quotation of additional securities and agreement For further information please download the attached PDF:

Oventus Medical Announce General Meeting Results (ASX:OVN)

BRISBANE, 9 September 2019: Oventus Medical Ltd (ASX: OVN) is pleased to announce the following results from the General Meeting held on 9 September 2019. For more information please download the a...read more

Oventus Announce FDA Clearance for O2Vent Optima Oral Device (ASX:OVN)

Oventus receives US FDA clearance for O2Vent® Optima oral device Key points: Oventus receives US FDA clearance for O2Vent® Optima oral device Clearance enables Oventus to comm...read more